group
streptococc
ga
pharyng
signific
caus
communityassoci
infect
document
constitut
revis
guidelin
infecti
diseas
societi
america
idsa
treatment
ga
pharyng
primari
object
guidelin
provid
recommend
manag
common
clinic
condit
among
adult
pediatr
patient
guidelin
address
issu
relat
diagnosi
streptococc
pharyng
treatment
patient
allerg
penicillin
guidelin
discuss
activ
surveil
test
prevent
strategi
section
guidelin
begin
specif
clinic
question
follow
number
recommend
summari
mostrelev
evid
support
recommend
area
controversi
data
limit
conflict
addit
research
need
indic
throughout
document
highlight
futur
research
section
summar
recommend
made
updat
guidelin
diagnosi
manag
ga
pharyng
panel
follow
process
use
develop
idsa
guidelin
includ
systemat
weight
strength
recommend
ie
strong
weak
qualiti
evid
ie
high
moder
low
low
use
grade
grade
recommend
assess
develop
evalu
system
tabl
detail
descript
method
background
evid
summari
support
recommend
found
full
text
guidelin
specif
treatment
recommend
regard
streptococc
pharyng
includ
tabl
ga
common
bacteri
caus
acut
pharyng
respons
sore
throat
visit
adult
children
accur
diagnosi
streptococc
pharyng
follow
appropri
antimicrobi
therapi
import
prevent
acut
rheumat
fever
prevent
suppur
complic
eg
peritonsillar
abscess
cervic
lymphaden
mastoid
possibl
invas
infect
improv
clinic
symptom
sign
rapid
decreas
contagi
reduct
transmiss
ga
famili
member
classmat
close
contact
patient
allow
rapid
resumpt
usual
activ
minim
potenti
advers
effect
inappropri
antimicrobi
therapi
although
acut
pharyng
one
frequent
ill
pediatrician
primari
care
physician
consult
estim
million
visit
per
year
unit
state
rel
small
percentag
patient
acut
pharyng
children
smaller
percentag
adult
ga
pharyng
moreov
sign
symptom
ga
nonstreptococc
pharyng
overlap
broadli
accur
diagnosi
basi
clinic
ground
alon
usual
imposs
except
rare
infect
certain
bacteri
pharyng
pathogen
eg
corynebacterium
diphtheria
neisseria
gonorrhoea
tabl
antimicrobi
therapi
proven
benefit
treatment
acut
pharyng
due
organ
ga
therefor
extrem
import
physician
exclud
diagnosi
ga
pharyng
prevent
inappropri
administr
antimicrobi
larg
number
patient
nonstreptococc
pharyng
therapi
unnecessarili
expos
patient
expens
hazard
antimicrobi
therapi
despit
improv
antimicrobi
prescrib
children
adult
acut
pharyng
substanti
number
patient
continu
receiv
inappropri
antimicrobi
therapi
inappropri
antimicrobi
use
upper
respiratori
tract
infect
includ
acut
pharyng
major
contributor
develop
antimicrobi
resist
among
common
pathogen
estim
econom
cost
pediatr
streptococc
pharyng
unit
state
rang
million
million
per
year
includ
indirect
cost
relat
parent
work
loss
addit
acut
diseas
streptococc
pharyng
import
lead
nonsuppur
postinfecti
disord
acut
rheumat
fever
without
carditi
well
poststreptococc
glomerulonephr
although
acut
rheumat
fever
uncommon
develop
countri
continu
lead
caus
acquir
heart
diseas
children
area
india
subsaharan
africa
part
australia
new
zealand
guidelin
updat
practic
guidelin
idsa
follow
clinic
question
address
guidelin
practic
guidelin
systemat
develop
statement
assist
practition
patient
make
decis
appropri
healthcar
specif
clinic
circumst
attribut
good
guidelin
includ
valid
reliabl
reproduc
clinic
applic
clinic
flexibl
clariti
multidisciplinari
process
review
evid
document
panel
multidisciplinari
expert
manag
streptococc
pharyng
children
adult
conven
panel
consist
internist
pediatrician
includ
adult
pediatr
infecti
diseas
specialist
gener
pediatrician
group
conven
facetofac
meet
outlin
guidelin
discuss
process
guidelin
develop
use
grade
approach
explain
grade
approach
offer
structur
systemat
transpar
process
formul
recommend
basi
explicit
criteria
go
beyond
qualiti
avail
evid
tabl
follow
seri
teleconfer
list
clinic
question
address
guidelin
gener
discuss
priorit
identifi
uptod
valid
systemat
review
medlin
databas
pubm
cochran
librari
select
case
also
refer
list
recent
narr
review
studi
topic
unless
specifi
otherwis
search
period
restrict
englishlanguag
literatur
articl
also
retriev
search
clinic
diagnosi
laboratori
diagnosi
symptom
sign
microbiolog
panel
member
contribut
refer
list
area
qualiti
evid
evalu
literatur
review
base
judgment
systemat
review
applic
addit
studi
publish
review
done
systemat
review
unavail
evalu
origin
studi
inform
judgment
qualiti
underli
evid
base
examin
studi
primari
key
search
term
follow
panel
met
occas
via
teleconfer
includ
subgroup
call
person
complet
work
guidelin
purpos
teleconfer
discuss
question
distribut
write
assign
final
recommend
member
panel
particip
prepar
review
draft
guidelin
feedback
obtain
extern
peer
review
guidelin
review
approv
idsa
standard
practic
guidelin
committe
spgc
idsa
board
director
prior
dissemin
member
expert
panel
compli
idsa
polici
regard
conflict
interest
requir
disclosur
financi
interest
might
constru
constitut
actual
potenti
appar
conflict
member
expert
panel
provid
conflict
interest
disclosur
statement
idsa
ask
identifi
tie
compani
develop
product
might
affect
promulg
guidelin
inform
request
regard
employ
consult
stock
ownership
honoraria
research
fund
expert
testimoni
membership
compani
advisori
committe
panel
made
decis
casebycas
basi
whether
individu
role
limit
result
conflict
limit
conflict
identifi
annual
interv
panel
chair
liaison
advisor
spgc
chair
determin
need
revis
updat
guidelin
basi
examin
current
literatur
necessari
entir
panel
reconven
discuss
potenti
chang
appropri
panel
recommend
full
revis
guidelin
idsa
spgc
idsa
board
director
review
approv
acut
ga
pharyng
certain
characterist
epidemiolog
clinic
featur
tabl
disord
primarili
diseas
children
year
age
temper
climat
usual
occur
winter
earli
spring
patient
ga
pharyng
commonli
present
sore
throat
gener
sudden
onset
pain
swallow
fever
headach
nausea
vomit
abdomin
pain
may
also
present
especi
children
examin
patient
tonsillopharyng
erythema
without
exud
often
tender
enlarg
anterior
cervic
lymph
node
lymphaden
find
may
includ
beefi
red
swollen
uvula
petechia
palat
excori
nare
especi
infant
scarlatiniform
rash
howev
none
find
specif
ga
pharyng
convers
absenc
fever
presenc
clinic
featur
conjunct
cough
hoars
coryza
anterior
stomat
discret
intraor
ulcer
lesion
viral
exanthema
diarrhea
strongli
suggest
viral
rather
streptococc
etiolog
broad
overlap
sign
symptom
streptococc
nonstreptococc
usual
viral
pharyng
abil
identifi
streptococc
pharyng
accur
basi
clinic
ground
alon
gener
poor
therefor
except
obviou
viral
clinic
epidemiolog
featur
present
laboratori
test
perform
determin
whether
ga
present
pharynx
effort
made
incorpor
clinic
epidemiolog
featur
acut
pharyng
score
system
attempt
predict
probabl
particular
ill
caus
ga
pharyng
clinic
score
system
help
identifi
patient
low
risk
streptococc
infect
perform
throat
cultur
radt
usual
unnecessari
howev
sign
symptom
streptococc
nonstreptococc
pharyng
overlap
broadli
diagnosi
made
requisit
diagnost
precis
basi
clinic
ground
alon
even
subject
clinic
featur
particular
score
system
confirm
streptococc
pharyng
time
particularli
case
children
clinic
diagnosi
ga
pharyng
made
certainti
even
experienc
physician
bacteriolog
confirm
requir
virus
common
caus
acut
pharyng
tabl
respiratori
virus
adenoviru
influenza
viru
parainfluenza
viru
rhinoviru
respiratori
syncyti
viru
frequent
caus
acut
pharyng
viral
agent
acut
pharyng
includ
coxsackieviru
echovirus
herp
simplex
viru
epsteinbarr
viru
frequent
caus
acut
pharyng
often
accompani
clinic
featur
infecti
mononucleosi
eg
gener
lymphadenopathi
splenomegali
system
infect
cytomegaloviru
rubella
viru
measl
viru
number
viral
agent
may
associ
acut
pharyng
human
metapneumoviru
human
bocaviru
may
caus
lower
respiratori
tract
infect
children
respect
role
caus
pharyng
unknown
ga
common
caus
bacteri
pharyng
bacteria
also
caus
acut
pharyng
tabl
arcanobacterium
haemolyticum
rare
caus
acut
pharyng
may
associ
rash
similar
seen
scarlet
fever
particularli
teenag
young
adult
n
gonorrhoea
occasion
caus
acut
pharyng
sexual
activ
person
infect
bacteria
francisella
tularensi
yersinia
enterocolitica
mix
infect
anaerob
bacteria
eg
vincent
angina
rare
caus
acut
pharyng
pathogen
mycoplasma
pneumonia
chlamydophila
pneumonia
uncommon
caus
acut
pharyng
bacteri
caus
acut
pharyng
includ
group
c
g
streptococci
c
diphtheria
group
c
streptococcu
gc
rel
common
caus
acut
pharyng
among
colleg
student
adult
addit
endem
pharyng
gc
caus
epidem
foodborn
pharyng
ingest
contamin
product
unpasteur
cow
milk
famili
school
outbreak
gc
pharyng
also
describ
even
though
sever
welldocu
foodborn
outbreak
group
g
streptococc
gg
pharyng
well
communitywid
respiratori
outbreak
gg
pharyng
children
etiolog
role
gg
acut
endem
pharyng
remain
unclear
acut
rheumat
fever
describ
complic
either
gc
gg
pharyng
report
attempt
link
acut
glomerulonephr
gg
pharyng
causal
relationship
establish
acut
glomerulonephr
complic
gc
pharyng
extrem
unusu
therefor
primari
reason
identifi
either
gc
gg
etiolog
agent
acut
pharyng
initi
antibiot
therapi
may
reduc
clinic
impact
ill
current
convinc
evid
control
studi
clinic
respons
antibiot
therapi
patient
acut
pharyng
either
gc
gg
isol
throat
sever
recent
report
document
isol
fusobacterium
necrophorum
throat
swab
adolesc
young
adult
nonstreptococc
pharyng
studi
also
suggest
role
f
necrophorum
case
recurr
persist
pharyng
without
bacteremia
lemierr
syndrom
f
necrophorum
caus
agent
case
lemierr
syndrom
requir
urgent
antibiot
therapi
present
evid
f
necrophorum
primari
pathogen
acut
pharyng
adolesc
young
adult
suggest
studi
requir
determin
role
f
necrophorum
acut
pharyng
well
necess
effect
antibiot
therapi
evid
list
potenti
etiolog
agent
ga
pharyng
commonli
occur
form
acut
pharyng
antibiot
therapi
definit
indic
therefor
patient
acut
pharyng
clinic
decis
usual
need
made
whether
pharyng
attribut
ga
cultur
throat
swab
sheepblood
agar
plate
standard
document
presenc
ga
pharyng
upper
respiratori
tract
confirm
clinic
diagnosi
acut
streptococc
pharyng
perform
correctli
cultur
singl
throat
swab
blood
agar
plate
sensit
detect
ga
pharyng
sever
variabl
affect
accuraci
throat
cultur
result
exampl
manner
swab
obtain
import
impact
yield
streptococci
throat
swab
specimen
obtain
surfac
either
tonsil
tonsillar
fossa
posterior
pharyng
wall
area
oral
pharynx
mouth
accept
site
healthcar
profession
tri
obtain
throat
swab
uncoop
child
without
immobil
neck
may
obtain
specimen
neither
adequ
repres
addit
falseneg
result
may
obtain
patient
receiv
antibiot
shortli
throat
swab
obtain
use
anaerob
incub
select
cultur
media
may
increas
proport
posit
cultur
result
conflict
data
regard
increas
cost
effort
associ
anaerob
incub
select
cultur
media
difficult
justifi
particularli
physician
process
throat
cultur
offic
anoth
variabl
affect
throat
cultur
result
durat
incub
plate
cultur
incub
hour
read
addit
incub
overnight
room
temperatur
may
identifi
number
addit
posit
throat
cultur
result
thu
although
initi
therapeut
decis
may
made
basi
overnight
cultur
advis
reexamin
plate
hour
yield
neg
result
hour
clinic
signific
number
ga
coloni
throat
cultur
plate
problemat
although
patient
true
acut
ga
pharyng
like
strongli
posit
cultur
patient
streptococc
carrier
ie
individu
chronic
ga
colon
pharynx
much
overlap
regard
permit
accur
differenti
basi
alon
major
disadvantag
throat
cultur
delay
overnight
longer
obtain
result
radt
develop
identif
ga
pharyng
directli
throat
swab
shorter
turnaround
time
rapid
identif
treatment
patient
ga
pharyng
reduc
risk
spread
allow
patient
return
school
work
sooner
reduc
acut
associ
morbid
use
radt
certain
popul
eg
patient
emerg
depart
report
significantli
increas
number
patient
appropri
treat
streptococc
pharyng
compar
tradit
throat
cultur
radt
current
avail
highli
specif
approxim
compar
blood
agar
plate
cultur
falseposit
test
result
highli
unusu
therefor
therapeut
decis
made
confid
basi
posit
test
result
unfortun
sensit
test
compar
blood
agar
plate
cultur
first
radt
use
latex
agglutin
method
rel
insensit
unclear
end
point
newer
test
base
enzym
immunoassay
techniqu
offer
increas
sensit
sharpli
defin
end
point
recent
radt
use
chemiluminesc
dna
probe
optic
immunoassay
develop
howev
optic
immunoassay
longer
commerci
avail
varieti
radt
avail
equal
perform
characterist
practition
awar
test
clinic
laboratori
improv
act
waiv
need
certif
use
nonwaiv
test
requir
proper
certif
physician
laboratori
neither
convent
throat
cultur
radt
accur
differenti
acut
infect
person
asymptomat
streptococc
carrier
intercurr
viral
pharyng
nevertheless
allow
physician
withhold
antibiot
great
major
patient
sore
throat
result
cultur
radt
neg
extrem
import
nation
patient
sore
throat
seen
primari
care
set
receiv
prescript
antimicrobi
like
ga
pharyng
radt
throat
cultur
may
affect
spectrum
bia
refer
phenomenon
greater
pretest
probabl
ga
pharyng
sensit
radt
throat
cultur
greater
sensit
variou
radt
studi
popul
children
adolesc
proport
acut
pharyng
due
ga
children
adolesc
suffici
high
neg
radt
accompani
followup
backup
throat
cultur
children
adolesc
necessari
adult
usual
circumst
note
measur
antistreptococc
antibodi
titer
often
use
diagnosi
nonsuppur
sequela
ga
pharyng
acut
rheumat
fever
acut
glomerulonephr
howev
test
use
diagnosi
acut
pharyng
antibodi
titer
commonli
use
test
antistreptolysin
aso
antidnas
b
may
reach
maximum
level
week
acut
ga
pharyng
infect
may
remain
elev
month
even
without
activ
ga
infect
ga
caus
case
acut
pharyng
adult
howev
risk
acut
pharyng
due
ga
among
adult
higher
parent
schoolag
children
whose
occup
bring
close
associ
children
risk
first
attack
arf
extrem
low
adult
even
undiagnos
untreat
episod
streptococc
pharyng
epidemiolog
distinct
use
clinic
algorithm
without
microbiolog
confirm
suggest
accept
altern
basi
diagnosi
infect
adult
emerg
depart
practic
algorithm
predict
posit
result
ga
throat
cultur
accuraci
depend
number
requir
clinic
featur
present
howev
use
diagnost
strategi
would
result
treatment
unaccept
larg
number
adult
nonstreptococc
pharyng
undesir
result
age
group
low
preval
ga
pharyng
low
risk
rheumat
fever
rheumat
carditi
howev
note
featur
acut
pharyng
adult
exclus
diagnosi
basi
neg
radt
result
without
confirm
neg
cultur
result
accept
altern
diagnosi
basi
throat
cultur
result
gener
high
specif
radt
minim
overprescript
antimicrobi
treatment
adult
latter
point
particular
import
view
nation
data
indic
expens
broaderspectrum
prescrib
approxim
threequart
adult
consult
commun
primari
care
physician
sore
throat
physician
wish
ensur
achiev
maxim
sensit
diagnosi
may
continu
use
convent
throat
cultur
back
neg
radt
result
cultur
note
ga
infect
children
year
old
often
associ
fever
mucopurul
rhiniti
excori
nare
diffus
adenopathi
exud
pharyng
rare
age
group
recent
metaanalysi
estim
higher
preval
rate
ga
pharyng
among
schoolag
children
compar
children
year
provid
support
routin
diagnost
test
age
group
howev
preval
ga
pharyng
significantli
lower
children
year
age
rang
correspond
rise
aso
requir
preval
low
thu
diagnost
test
ga
pharyng
routin
indic
children
year
age
one
main
indic
prompt
test
treatment
ga
pharyng
prevent
arf
report
arf
children
year
age
rare
new
case
arf
report
salt
lake
citi
utah
involv
individu
year
age
patient
median
age
year
countri
arf
common
unit
state
rate
among
young
children
also
low
thought
may
take
repeat
exposur
ga
prime
immun
system
immun
respons
streptococc
pharyng
lead
rheumat
fever
low
preval
ga
pharyng
low
risk
develop
arf
children
year
age
limit
use
diagnost
test
age
group
howev
child
year
age
household
contact
schoolag
sibl
document
streptococc
pharyng
reason
consid
test
child
child
symptomat
previou
famili
studi
demonstr
high
rate
secondari
streptococc
infect
among
household
contact
likelihood
spread
infect
famili
high
index
subject
symptomat
pharyng
studi
demonstr
onethird
person
semiclos
commun
develop
symptomat
pharyng
outbreak
therefor
child
day
care
anoth
set
high
rate
case
ga
infect
reason
test
symptomat
children
treat
found
posit
ga
patient
prescrib
antibiot
treatment
streptococc
pharyng
clinic
respons
usual
achiev
within
hour
therapi
import
note
streptococc
pharyng
usual
selflimit
diseas
even
without
treatment
fever
symptom
commonli
resolv
within
day
onset
ill
persist
symptom
beyond
period
suggest
either
develop
suppur
complic
child
may
chronic
carrier
ga
rather
acut
infect
intercurr
communityacquir
viral
pharyng
see
question
v
streptococc
carrier
therefor
followup
cultur
routin
recommend
followup
test
cours
treatment
appropri
antibiot
reserv
patient
particularli
high
risk
arf
recurr
classic
symptom
compat
ga
pharyng
describ
previous
despit
univers
suscept
ga
penicillin
children
treat
appropri
antibiot
appar
streptococc
pharyng
throat
cultur
posit
ga
end
therapi
children
consid
bacteriolog
failur
circumst
children
actual
streptococc
carrier
antimicrobi
therapi
indic
see
question
v
streptococc
carrier
asymptomat
carriag
ga
frequent
note
among
household
contact
patient
ga
pharyng
onethird
household
includ
individu
develop
symptomat
ga
pharyng
warrant
diagnost
test
treatment
studi
examin
role
antibiot
prophylaxi
household
contact
patient
ga
pharyng
penicillin
prophylaxi
shown
reduc
incid
subsequ
ga
pharyng
although
small
statist
signific
effect
secondari
ill
shown
cephalosporin
prophylaxi
antibiot
use
associ
advers
side
effect
rash
diarrhea
rare
anaphylaxi
unnecessari
use
broadspectrum
antibiot
lead
concern
potenti
spread
antibioticresist
organ
popul
given
selflimit
natur
ga
pharyng
high
frequenc
ga
throat
carriag
limit
efficaci
antibiot
prophylaxi
potenti
concern
direct
indirect
risk
associ
antibiot
use
routin
test
treatment
asymptomat
household
contact
patient
ga
pharyng
warrant
select
antimicrobi
treatment
ga
pharyng
import
issu
consid
includ
efficaci
safeti
antimicrobi
spectrum
narrow
vs
broad
dose
schedul
complianc
therapi
ie
adher
cost
factor
influenc
costeffect
antimicrobi
therapi
number
antibiot
shown
effect
treat
ga
pharyng
tabl
includ
penicillin
congen
eg
ampicillin
amoxicillin
well
numer
cephalosporin
macrolid
clindamycin
penicillin
howev
remain
treatment
choic
proven
efficaci
safeti
narrow
spectrum
low
cost
penicillinresist
ga
never
document
amoxicillin
often
use
place
penicillin
v
oral
therapi
young
children
efficaci
appear
equal
choic
primarili
relat
accept
tast
suspens
compar
clinic
trial
oncedaili
amoxicillin
mgkg
maximum
mg
day
shown
effect
ga
pharyng
somewhat
broaderspectrum
agent
advantag
oncedaili
dose
may
enhanc
adher
rel
inexpens
palat
oral
antibiot
must
administ
convent
day
achiev
maxim
rate
pharyng
erad
ga
current
us
food
drug
administr
approv
cefdinir
cefpodoxim
azithromycin
cours
therapi
ga
pharyng
howev
mani
studi
shortcours
cephalosporin
therapi
lack
strict
entri
criteria
includ
assess
complianc
therapi
includ
serotyp
genotyp
differenti
infect
treatment
fail
newli
acquir
infect
addit
spectra
antibiot
much
broader
spectrum
penicillin
even
antibiot
administ
short
cours
expens
therefor
use
shorter
cours
oral
cephalosporin
endors
time
antimicrobi
ga
pharyng
may
given
either
oral
parenter
intramuscular
benzathin
penicillin
g
therapi
prefer
patient
deem
unlik
complet
full
cours
oral
therapi
certain
antimicrobi
recommend
treatment
ga
pharyng
tetracyclin
use
high
preval
resist
strain
sulfonamid
trimethoprimsulfamethoxazol
use
erad
ga
patient
acut
pharyng
older
fluoroquinolon
eg
ciprofloxacin
limit
activ
ga
pharyng
use
treat
ga
pharyng
newer
fluoroquinolon
eg
levofloxacin
moxifloxacin
activ
vitro
ga
expens
unnecessarili
broad
spectrum
activ
therefor
recommend
routin
treatment
ga
pharyng
cours
oral
cephalosporin
recommend
penicillinallerg
individu
tabl
narrowspectrum
cephalosporin
cefadroxil
cephalexin
much
prefer
broadspectrum
cephalosporin
cefaclor
cefuroxim
cefixim
cefdinir
cefpodoxim
oral
broadspectrum
cephalosporin
consider
expens
penicillin
amoxicillin
former
agent
like
select
antibioticresist
flora
penicillinallerg
person
also
allerg
cephalosporin
agent
use
patient
immedi
anaphylactictyp
hypersensit
penicillin
clindamycin
resist
among
ga
isol
unit
state
approxim
reason
agent
treat
penicillinallerg
patient
oral
macrolid
erythromycin
clarithromycin
azalid
azithromycin
dose
mgkgday
maximum
mg
also
reason
patient
allerg
penicillin
ten
day
therapi
indic
azithromycin
given
day
erythromycin
associ
substanti
higher
rate
gastrointestin
side
effect
agent
strain
ga
resist
agent
highli
preval
area
world
result
treatment
failur
recent
year
macrolid
resist
rate
among
pharyng
isol
area
unit
state
around
one
studi
suggest
day
clarithromycin
may
effect
erad
ga
pharyng
day
azithromycin
multipl
studi
includ
random
doubleblind
placebocontrol
studi
support
benefit
nsaid
ibuprofen
reduc
fever
pain
rel
placebo
among
children
adult
pharyng
signific
advers
event
note
random
doubleblind
placebocontrol
studi
significantli
greater
pain
relief
use
acetaminophen
compar
placebo
document
among
children
adult
although
improv
symptom
alway
equival
obtain
use
ibuprofen
although
aspirin
also
shown
reduc
pain
adult
upper
respiratori
tract
infect
recommend
use
aspirin
pain
relief
pharyng
children
risk
rey
syndrom
result
random
doubleblind
placebocontrol
studi
demonstr
corticosteroid
decreas
durat
sever
sign
symptom
ga
pharyng
adult
children
although
actual
decreas
pain
durat
minim
approxim
hour
difficult
compar
magnitud
effect
across
variou
studi
differ
agent
select
rout
dosag
use
method
assess
pain
time
followup
limit
followup
telephon
effect
concomit
administr
nsaid
acetaminophen
patient
unclear
although
advers
effect
therapi
evid
publish
data
longterm
followup
done
given
efficaci
antimicrobi
selflimit
natur
ga
pharyng
efficaci
system
topic
analges
decreas
acut
symptom
ga
pharyng
potenti
advers
effect
system
steroid
recommend
use
corticosteroid
therapi
ill
varieti
topic
agent
market
therapi
acut
pharyng
includ
rins
spray
lozeng
sever
contain
topic
anesthet
ambroxol
lidocain
benzocain
may
give
temporari
symptomat
relief
lozeng
may
effect
repres
choke
hazard
young
children
topic
agent
pharyng
children
adult
recent
review
remedi
commonli
use
patient
old
enough
salt
water
studi
detail
routin
posttherapi
retest
longer
advis
patient
acut
ga
pharyng
recurr
sign
symptom
acut
pharyng
within
week
month
complet
therapi
acut
pharyng
like
seek
reassess
symptomat
patient
posit
cultur
andor
radt
result
sever
possibl
explan
noncompli
prescrib
antibiot
new
ga
pharyng
infect
acquir
famili
contact
classroom
contact
commun
contact
chronic
ga
carriag
intercurr
viral
infect
second
episod
pharyng
caus
origin
infect
strain
ga
rule
less
common
chronic
pharyng
carrier
ga
present
pharynx
evid
activ
immunolog
respons
organ
rise
antistreptococc
antibodi
titer
winter
spring
temper
climat
mani
asymptomat
schoolag
children
may
ga
carrier
may
colon
ga
pharyng
month
time
may
experi
episod
intercurr
viral
pharyng
test
patient
often
demonstr
evid
ga
pharynx
thu
may
mimic
patient
acut
streptococc
pharyng
individu
identifi
chronic
pharyng
ga
carrier
ordinarili
requir
antimicrobi
therapi
carrier
appear
unlik
spread
organ
close
contact
thought
low
risk
develop
suppur
invas
complic
nonsuppur
complic
eg
acut
rheumat
fever
addit
much
difficult
erad
ga
pharyng
throat
carrier
patient
bona
fide
acut
streptococc
infect
particularli
true
penicillin
amoxicillin
therapi
may
also
true
antimicrobi
clinic
epidemiolog
evid
suggest
publish
studi
show
penicillin
amoxicillin
rel
high
failur
rate
erad
ga
pharyng
patient
popul
like
contamin
chronic
carrier
antimicrobi
therapi
indic
larg
major
chronic
streptococc
carrier
howev
special
situat
erad
carriag
may
desir
includ
follow
commun
outbreak
acut
rheumat
fever
acut
poststreptococc
glomerulonephr
invas
ga
infect
outbreak
ga
pharyng
close
partial
close
commun
presenc
famili
person
histori
acut
rheumat
fever
famili
excess
anxieti
ga
infect
tonsillectomi
consid
carriag
number
antimicrobi
schedul
demonstr
substanti
effect
penicillin
amoxicillin
elimin
chronic
streptococc
carriag
tabl
routin
practic
often
difficult
differenti
ga
carrier
intercurr
viral
infect
patient
acut
streptococc
pharyng
help
clue
includ
patient
age
season
local
epidemiolog
characterist
eg
local
preval
influenza
andor
enterovir
ill
precis
natur
present
sign
symptom
tabl
mani
instanc
howev
clinician
may
abl
distinguish
persist
carriag
acut
infect
elect
administ
anoth
cours
antimicrobi
singl
episod
pharyng
associ
laboratori
confirm
ga
occur
shortli
complet
cours
appropri
antimicrobi
therapi
treatment
agent
list
tabl
appropri
sinc
patient
adher
oral
antimicrobi
therapi
often
issu
intramuscular
benzathin
penicillin
g
consid
individu
second
episod
necessari
obtain
addit
throat
swab
specimen
cultur
second
cours
therapi
unless
patient
remain
becom
symptomat
unless
one
special
circumst
note
present
even
challeng
clinic
circumst
person
usual
schoolag
child
adolesc
within
period
month
year
experi
multipl
episod
acut
pharyng
cultur
andor
radt
result
identifi
ga
like
patient
chronic
streptococc
carrier
experienc
repeat
viral
infect
patient
frequent
discret
episod
inform
regard
precis
natur
present
sign
symptom
tabl
clinic
respons
antibiot
therapi
presenc
absenc
ga
pharyng
cultur
throat
swab
obtain
asymptomat
interv
help
distinguish
persist
carriag
recurr
episod
acut
ga
pharyng
serotyp
genotyp
streptococc
isol
recov
specimen
obtain
distinct
episod
individu
patient
may
also
assist
arriv
determin
carrier
persist
strain
ga
time
unfortun
studi
avail
special
research
laboratori
unlik
avail
within
practic
time
frame
definit
control
studi
treatment
multipl
repeat
symptomat
episod
cultureposit
acut
pharyng
person
howev
regimen
list
tabl
report
result
low
rate
bacteriolog
failur
continu
antimicrobi
prophylaxi
recommend
except
prevent
recurr
arf
patient
experienc
previou
episod
rheumat
fever
physician
suspect
pingpong
spread
infect
explan
multipl
recurr
episod
infect
within
famili
may
help
obtain
throat
swab
famili
contact
simultan
treat
cultur
radt
result
posit
credibl
evid
famili
pet
reservoir
ga
pharyng
contribut
famili
spread
tonsillectomi
may
consid
rare
patient
whose
symptomat
episod
diminish
frequenc
time
altern
explan
recurr
ga
pharyng
evid
howev
tonsillectomi
demonstr
benefici
rel
small
group
patient
benefit
expect
rel
shortliv
futur
research
focu
follow
improv
rapid
method
diagnosi
acut
ga
pharyng
distinguish
acut
infect
chronic
pharyng
carriag
develop
simpler
shorter
therapeut
regimen
acut
ga
pharyng
develop
afford
safe
effect
ga
vaccin
broad
spectrum
ga
organ
